Related references
Note: Only part of the references are listed.Telomerase-Targeted Cancer Immunotherapy
Eishiro Mizukoshi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis
Xiao Liu et al.
SCIENCE ADVANCES (2019)
ZEB1 stimulates breast cancer growth by up-regulating hTERT expression
Pan Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Diversity and functional evolution of the plasminogen activator system
Rishi Kumar Jaiswal et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
KLF4 signalling in carcinogenesis and epigenetic regulation of hTERT
Suresh Singh Yadav et al.
MEDICAL HYPOTHESES (2018)
hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells
Rishi K. Jaiswal et al.
MOLECULAR CARCINOGENESIS (2018)
Telomerase reverse transcriptase coordinates with the epithelial-to-mesenchymal transition through a feedback loop to define properties of breast cancer stem cells
Ahmed El-Badawy et al.
BIOLOGY OPEN (2018)
The Telomerase and Alternative Lengthening of Telomeres Mechanisms Regulate Laryngeal Cancer Cell Apoptosis via the PI3K/Akt Pathway
Fei Wang et al.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY (2018)
Proteomic identification of proteins differentially expressed following overexpression of hTERT (human telomerase reverse transcriptase) in cancer cells
Rishi Kumar Jaiswal et al.
PLOS ONE (2017)
BRCA1/2 mutations perturb telomere biology: characterization of structural and functional abnormalities in vitro and in vivo
Orit Uziel et al.
ONCOTARGET (2016)
An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer
Yong Qin et al.
ONCOTARGET (2016)
Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype
Ana Kulic et al.
MEDICAL ONCOLOGY (2016)
Telomere and Telomerase Therapeutics in Cancer
Yucheng Xu et al.
GENES (2016)
Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells
Yaojian Rao et al.
BREAST CANCER (2016)
A historic and scientific review of breast cancer: The next global healthcare challenge
Sven Becker
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2015)
Telomere shortening in breast cancer correlates with the pathological features of tumor progression
Makoto Kammori et al.
ONCOLOGY REPORTS (2015)
A simple, fast and highly sensitive assay for the detection of telomerase activity
Quang Huy Quach et al.
CHEMICAL COMMUNICATIONS (2013)
Telomerase as a useful target in cancer fighting-the breast cancer case
Hanna Holysz et al.
TUMOR BIOLOGY (2013)
Telomerase and its extracurricular activities
Rishi Kumar Jaiswal et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2013)
Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes
Christopher M. Heaphy et al.
MODERN PATHOLOGY (2011)
Human telomerase activity regulation
Aneta Wojtyla et al.
MOLECULAR BIOLOGY REPORTS (2011)
Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome
Lingeng Lu et al.
BREAST CANCER RESEARCH (2011)
Gefitinib Induces Apoptosis and Decreases Telomerase Activity in MDA-MB-231 Human Breast Cancer Cells
Dong-Oh Moon et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms
Yuanyuan Li et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Pectenotoxin-2 represses telomerase activity in human leukemia cells through suppression of hTERT gene expression and Akt-dependent hTERT phosphorylation
Mun-Ock Kim et al.
FEBS LETTERS (2008)
Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer
Amelia E. Hochreiter et al.
CLINICAL CANCER RESEARCH (2006)
Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma
AK Meeker et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells
CY Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
BRCA1 inhibition of telomerase activity in cultured cells
JB Xiong et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Regulation of HER2/Neu promoter activity by the ETS transcription factor, ER81
DG Bosc et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues
E Hiyama et al.
NEOPLASIA (2001)
Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells
DW Xu et al.
ONCOGENE (2000)
Spl cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)
S Kyo et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
